Endovaskulyarnye metody issledovaniya i lecheniya v kardiologii: vremya yubileev i somneniy
- Authors: Gorgadze TT1, Danilov NM1, Savchenko AP1, Chazova IE1
-
Affiliations:
- Issue: Vol 5, No 2 (2008)
- Pages: 67-76
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33074
- DOI: https://doi.org/10.26442/SG33074
- ID: 33074
Cite item
Full Text
Abstract
References
- Бабунашвили А.М., Рабкин И.Х. Иванов В.А. Коронарная ангиопластика. М., 1996.
- Serruys PW, Luijten HE, Beatt KJ et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. Circulation 1988; 77: 361-71.
- Nobuyoshi M, Kimura T, Nosoka H et al. Restenosis after successful Percutaneous transluminal coronary angioplasty. Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-23.
- Williams DO, Joelson JM, Most AS. Angiographic findings when chest pain recurs after successful percutaneous transluminal coronary angioplasty. Am J Cardiology 1987; 60: 792-5.
- Meier B. Use and Abuse of Coronary Stenting. Hospital Chronicles 2006; Suppl.: 99-103.
- Daemen J, Serruys PW. Drug-Eluting Stent Update 2007. Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same? Circulation 2007; 116: 316-28.
- Camenzind E. ESC Congress News 2006, September.
- Stone GW et al. New Engl J Med 2007; 356: 998-1008.
- Lagerqvist B, James SK et al. Long-term outcomes with drug eluting stents versus bare-metal stents in Sweden. New Engl J Med 2007; 356: 1009-19.
- Tu JV, Bowen J et al. Effectiveness and safety of drug-eluting stents in Ontario. New Engl J Med 2007; 357: 1393-402.
- Stettler C et al. Lancet 2007; 370: 937-48.
- Marroquin OC, Kip KE, Kelley DE et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004; 109: 714-21.
- Cutlip DE, Chauhan MS, Baim DS et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002; 40: 2082-9.
- Pache J, Kastrati A, Mehilli J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003; 41: 1283-8.
- Piatti P, Di Mario C, Monti LD et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003; 108: 2074-81.
- Rana JS, Monraats PS et al. Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention.
- Detre KM et al. Circulation 1999; 99: 316-28.
- Bravata DM et al. Ann Intern Med 2007; 147.